Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric...
Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023
About this item
Full title
Author / Creator
Publisher
England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Although the emergence of immunotherapy has benefited patients with advanced gastric cancer (AGC), the magnitude of the benefit among real-world patients with HER2-negative AGC remains unclear.
The current study aimed to evaluate the treatment features across various immunotherapy approval periods and investigate the utility of immunotherapy for...
Alternative Titles
Full title
Investigating the role of immunotherapy for real-world patients with HER2-negative advanced gastric cancer between 2011 and 2023
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e4715b7695d14c5cb0624d73f226847a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4715b7695d14c5cb0624d73f226847a
Other Identifiers
ISSN
1758-8359,1758-8340
E-ISSN
1758-8359
DOI
10.1177/17588359251322670
